COMPASS PATHWAYS PLC Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
COMPASS PATHWAYS PLC (CMPS) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $15.00 million as of 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-03-24
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $15.00M.
- 2024-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $25.50M.
- 2024-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $39.00M.
- 2023-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $29.60M; Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount as first filed $29.70M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount as first filed |
|---|---|---|
| 2025-12-31 | $15.00M 10-K · filed 2026-03-24 | |
| 2024-12-31 | $25.50M 10-K · filed 2026-03-24 | |
| 2024-03-31 | $39.00M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $29.60M 10-K · filed 2025-02-27 | $29.70M 10-K · filed 2024-02-29 |
| 2023-09-30 | $35.00M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $38.50M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $42.30M 10-Q · filed 2024-05-08 | |
| 2022-12-31 | $30.40M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $30.70M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $29.70M 10-Q · filed 2023-08-03 | |
| 2022-03-31 | $35.20M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $27.40M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $27.60M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $21.50M 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $21.60M 10-Q · filed 2022-05-10 | |
| 2020-12-31 | $18.10M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |